FDA approval of ICOTYDE ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide 18 March
Johnson & Johnson highlights promising first-in-human Erda-iDRS results in intermediate-risk non-muscle-invasive bladder cancer 13 March
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients 12 March
